28.1 Peripheral Neuropathies: Bell's Palsy, Carpal Tunnel & Radiculopathy

Bell's Palsy: Clinical Neuroanatomy, Diagnostic Assessment & Management

Acute peripheral facial nerve palsy (Bell's palsy) is the most frequent cause of acute spontaneous unilateral facial paralysis, accounting for approximately 60% to 75% of all peripheral facial palsy presentations. Understanding its underlying neuroanatomy and pathophysiological mechanics is critical for rapid bedside differentiation from life-threatening central vascular emergencies.

Neuroanatomy & Pathophysiology

The facial nerve (cranial nerve VII) originates in the caudal pontine tegmentum and traverses the cerebellopontine angle alongside cranial nerve VIII. It enters the internal acoustic meatus and proceeds through the narrow, tortuous bony fallopian canal within the petrous temporal bone. The fallopian canal contains the labyrinthine segment, which represents the narrowest constriction of the entire facial nerve course (often <0.7 mm in diameter).

Underlying reactivation of latent herpes simplex virus type 1 (HSV-1)—or less commonly, other viral pathogens such as Epstein-Barr virus (EBV) or cytomegalovirus (CMV)—triggers an intense local inflammatory response. Due to the rigid, non-distensible bony walls of the labyrinthine segment, inflammatory edema produces progressive intraneural vascular compression, secondary microvascular ischemia, and conduction block (neuropraxia) or mechanical axonal disruption.

Beyond supplying somatic motor fibers to all muscles of facial expression, the facial nerve carries distinct functional fiber systems whose impairment localized within the fallopian canal produces accompanying clinical deficits:

1. Branchial Somatic Motor Fibers: Innervate the frontalis, orbicularis oculi, buccinator, orbicularis oris, platysma, and the stapedius muscle in the middle ear. Paralysis of the stapedius muscle abolishes the acoustic stapedial reflex, producing painful acoustic hypersensitivity (hyperacusis), where ordinary sounds are perceived as uncomfortably loud.
2. Special Visceral Sensory (Taste) Fibers: Carried via the chorda tympani nerve to innervate taste buds across the anterior two-thirds of the tongue. Patients frequently report dysgeusia, hypogeusia, or a metallic gustatory sensation.
3. General Visceral Parasympathetic Fibers: Carried via the greater petrosal nerve to the lacrimal gland (regulating tearing) and via the chorda tympani to the submandibular and sublingual salivary glands. Interruption can result in decreased ipsilateral tear production (dry eye); paradoxically, patients often report epiphora (overflow tearing) due to severe orbicularis oculi weakness that abolishes normal blinking and prevents mechanical pumping of tears into the nasolacrimal duct.

---

The Forehead-Sparing Rule: UMN vs. LMN Facial Weakness

The most pivotal bedside neurological discrimination is differentiating a peripheral lower motor neuron (LMN) facial palsy (e.g., Bell's palsy) from a central upper motor neuron (UMN) lesion (e.g., ischemic stroke involving the motor cortex or corticobulbar tract).

               CENTRAL (UMN) vs. PERIPHERAL (LMN) FACIAL INNERVATION

     Contralateral Motor Cortex              Ipsilateral Motor Cortex
          │             │                          │             │
          │             │                          │             │
          ▼             ▼                          ▼             ▼
   ┌───────────────┐ ┌───────────────┐      ┌───────────────┐ ┌───────────────┐
   │ Upper Nucleus │ │ Lower Nucleus │      │ Upper Nucleus │ │ Lower Nucleus │
   │ (Forehead/Eye)│ │ (Mouth/Cheek) │      │ (Forehead/Eye)│ │ (Mouth/Cheek) │
   └───────┬───────┘ └───────┬───────┘      └───────┬───────┘ └───────┬───────┘
           │  Bilateral      │ Contralateral        │  Bilateral      │ Contralateral
           │  Innervation    │ Innervation          │  Innervation    │ Innervation
           ▼                 ▼                      ▼                 ▼
   =========================================================================
   UMN Lesion (Stroke): Forehead SPARED      LMN Lesion (Bell's): COMPLETE HEMIFACIAL
   - Contralateral lower face droop          - Inability to wrinkle forehead
   - Normal forehead wrinkling & eye closure - Inability to close eye (lagophthalmos)
   - Preserved eyebrow elevation             - Lower facial droop & smile asymmetry

Critical Anatomical Rule

• The facial motor nucleus in the caudal pons is anatomically split into an upper subnucleus (which supplies the frontalis and orbicularis oculi muscles) and a lower subnucleus (which supplies the muscles of the lower face, including the buccinator, orbicularis oris, and platysma).
• The upper subnucleus receives bilateral corticobulbar motor input from both the left and right cerebral motor cortices.
• In contrast, the lower subnucleus receives strictly contralateral corticobulbar motor input from the opposite motor cortex.
• Central UMN Lesion (Stroke / TIA / Intracranial Mass): An ischemic cortical infarction spares the ipsilateral motor projections to the upper subnucleus. Consequently, forehead wrinkling and eyebrow elevation are fully preserved, while the contralateral lower face exhibits marked weakness (flattened nasolabial fold, drooping oral commissure).
• Peripheral LMN Lesion (Bell's Palsy / Facial Nerve Compression): Any lesion at or distal to the facial motor nucleus in the pons compromises all axonal projections to that half of the face. Therefore, there is flaccid weakness involving BOTH the upper and lower face: the patient cannot wrinkle the forehead, cannot tightly close the eye (lagophthalmos), exhibits an upward rolling of the eye upon attempted closure (Bell's phenomenon), and displays a flattened nasolabial fold with unilateral oral droop.

---

Clinical Staging: The House-Brackmann Facial Nerve Grading System

The severity and recovery of facial nerve dysfunction are universally quantified using the House-Brackmann (HB) Facial Nerve Grading System:

---

Ramsay Hunt Syndrome (Herpes Zoster Oticus)

Ramsay Hunt syndrome represents the second most common cause of acute atraumatic peripheral facial paralysis (accounting for ~10-15% of cases), provoked by reactivation of latent varicella-zoster virus (VZV) within the geniculate ganglion of cranial nerve VII.

Diagnostic Triad

1. Peripheral Lower Motor Neuron Facial Palsy: Indistinguishable on motor testing from severe Bell's palsy (House-Brackmann Grade IV-VI).
2. Severe, Debilitating Otalgia: Intense burning, throbbing, or lancinating deep ear and mastoid pain, typically preceding facial weakness by 24 to 72 hours.
3. Vesicular Cutaneous Eruption: Painful, erythematous herpetic vesicles located on the pinna, conchal bowl, external auditory canal, tragus, or tympanic membrane. In some cases, vesicles appear on the anterior two-thirds of the tongue or soft palate.

• Clinical Red Flag / Cranial Polyneuropathy: Due to intimate anatomical proximity within the internal acoustic meatus, VZV frequently spreads to involve cranial nerve VIII, causing severe sensorineural hearing loss, tinnitus, and acute rotational vertigo.
• Treatment: Ramsay Hunt carries a significantly worse prognosis than Bell's palsy (<50% complete recovery if untreated). Mandatory therapy requires immediate initiation of high-dose oral corticosteroids (Prednisone 60-80 mg daily) combined with high-dose oral antivirals (Valacyclovir 1,000 mg TID or Famciclovir 500 mg TID for 7 to 10 days).

---

Evidence-Based Medical Management of Bell's Palsy

                  BELL'S PALSY TREATMENT PROTOCOL

     Acute Onset Unilateral LMN Facial Weakness Peaking <=72 Hours
                                 │
                                 ▼
              Examine Concha, EAC, Oral Cavity & Cranial Nerves
                                 │
            ┌────────────────────┴────────────────────┐
            ▼                                         ▼
Vesicles Present (Ramsay Hunt)            Normal Skin & Mucosa (Bell's)
Oral Prednisone 60-80 mg daily            Oral Prednisone 60-80 mg daily
          PLUS                                      PLUS
Oral Valacyclovir 1000 mg TID             Optional Valacyclovir (Severe HB IV-VI)
    (Both for 7-10 days)                  Rigorous Eye Protection Protocol

Corticosteroid Pharmacotherapy

• First-Line Standard of Care: Extensive Cochrane systematic reviews and landmark randomized trials (including the Sullivan 2007 NEJM and Engström 2008 Lancet trials) confirm that oral corticosteroids initiated within 72 hours of symptom onset significantly increase complete recovery rates (from ~65-70% to >85-90%) and reduce long-term sequelae such as contracture and autonomic synkinesis (e.g., crocodile tears syndrome / Bogorad syndrome).
• Standard Dosing Regimen: Prednisone 60 to 80 mg PO daily for 7 days, followed by a 5-day taper (e.g., 50 mg, 40 mg, 30 mg, 20 mg, 10 mg daily), for a total treatment duration of 10 to 12 days.
• Time Sensitivity: Corticosteroids started beyond 72 hours show minimal to no statistically significant therapeutic benefit compared to placebo, as neural edema and secondary axonal loss have already evolved.

Role of Antiviral Therapy

• Adding an oral antiviral agent (Valacyclovir 1,000 mg PO TID or Acyclovir 400 mg PO five times daily for 7 days) to corticosteroids has not shown statistically significant benefit in mild-to-moderate Bell's palsy (House-Brackmann II-III).
• However, in patients presenting with severe facial paralysis (House-Brackmann IV, V, or VI), high-quality guidelines (AAO-HNS 2013, Canadian Practice Guidelines) suggest offering combined therapy (Prednisone + Valacyclovir), given modest trends toward improved functional recovery and minimal adverse drug events. Antivirals as monotherapy without steroids are strictly ineffective and must not be used.

Mandatory Eye Protection Protocol (Preventing Corneal Blindness)

Incomplete eyelid closure (lagophthalmos) combined with impaired lacrimal gland output eliminates the protective tear film. Unopposed environmental exposure rapidly triggers exposure keratitis, secondary corneal desiccation, epithelial defects, bacterial ulceration, and permanent corneal scarring:

1. Daytime Lubrication: Preservative-free lubricating artificial tears (hypromellose or carboxymethylcellulose) instilled every 1 to 2 hours while awake.
2. Nighttime Protection: Application of high-viscosity ophthalmic lubricating ointment (white petrolatum / mineral oil) inside the lower conjunctival sac immediately before sleep.
3. Bedtime Taping / Moisture Chamber: Careful mechanical taping of the upper eyelid closed using hypoallergenic paper tape, or wearing a protective transparent moisture chamber (bubble eye shield) overnight.
4. Urgent Ophthalmology Referral: Indicated immediately if the patient develops eye pain, ocular erythema, foreign body sensation, or decreased visual acuity.

Diagnostic Red Flags & Imaging Indications

Bell's palsy is a clinical diagnosis. Routine laboratory testing and head CT/MRI are NOT indicated for acute typical presentations. However, contrast-enhanced Brain MRI with internal auditory canal (IAC) protocol is mandatory if:

• Weakness progresses beyond 3 weeks from onset;
• No signs of facial motor recovery appear after 3 to 4 months;
• Other cranial neuropathies are present (excluding hyperacusis or chorda tympani taste loss);
• Isolated, selective branch weakness occurs (e.g., isolated marginal mandibular palsy, strongly suggesting a parotid gland neoplasm);
• Recurrent unilateral or alternating bilateral facial paralysis (concerning for sarcoidosis [Heerfordt syndrome], Lyme disease, lymphoma, or Melkersson-Rosenthal syndrome).

---

Carpal Tunnel Syndrome (CTS): Diagnosis & Stepwise Management

Carpal tunnel syndrome (CTS) is the most prevalent compressive entrapment neuropathy, affecting 3% to 6% of the general adult population. It results from elevated interstitial pressure within the rigid, fibro-osseous carpal canal, producing mechanical ischemia and demyelination of the median nerve.

Anatomy of the Carpal Tunnel

The carpal tunnel is bound deeply by the carpal bones (sulcus carpi) and superficially by the dense transverse carpal ligament (flexor retinaculum). The tunnel accommodates 10 rigid anatomical structures:

• 4 tendons of the flexor digitorum superficialis (FDS);
• 4 tendons of the flexor digitorum profundus (FDP);
• 1 tendon of the flexor pollicis longus (FPL);
• The median nerve.

Critical Anatomical Nuance: The palmar cutaneous branch of the median nerve arises approximately 5 to 7 cm proximal to the wrist crease and courses superficial to the transverse carpal ligament. Consequently, sensation over the thenar eminence is anatomically spared in isolated carpal tunnel syndrome. Loss of thenar sensation indicates a proximal lesion at the forearm level (pronator teres syndrome) or cervical radiculopathy (C6 root impingement).

                 ANATOMICAL DISTRIBUTION OF CARPAL TUNNEL

                     [Volan Aspect of Right Hand]

         Digit I       Digit II      Digit III      Digit IV      Digit V
         (Thumb)       (Index)       (Middle)        (Ring)      (Little)
        ┌───────┐     ┌───────┐     ┌───────┐     ┌───┬───┐     ┌───────┐
        │Median │     │Median │     │Median │     │Med│Uln│     │ Ulnar │
        │ Nerve │     │ Nerve │     │ Nerve │     │Nrv│Nrv│     │ Nerve │
        └───────┘     └───────┘     └───────┘     └───┴───┘     └───────┘
              \           │           /             /               │
               \          │          /             /                │
                ▼         ▼         ▼             ▼                 │
             ┌───────────────────────────────┐                      │
             │   MEDIAN NERVE PARESTHESIAS   │                      │
             └───────────────┬───────────────┘                      │
                             │                                      ▼
             ┌───────────────┴───────────────┐             ┌─────────────────┐
             │ Thenar Eminence Sensation     │             │ Entire Digit V  │
             │ SPARED (Palmar Cutaneous Br.) │             │ Completely      │
             └───────────────────────────────┘             │ NORMAL          │
                                                           └─────────────────┘

Clinical Presentation

• Nocturnal Acroparesthesias: Tingling, burning, numbness, and aching pain localized to the palmar surface of the thumb, index finger, middle finger, and the radial half of the ring finger. Symptoms characteristically wake the patient from sleep due to prolonged wrist flexion and recumbent interstitial fluid redistribution.
• The 'Flick Sign': Relief of paresthesias following vigorous shaking, flicking, or massaging of the affected wrist/hand (sensitivity ~93%, specificity ~96%).
• Motor Involvement: With prolonged axonal injury, patients develop weakness of the abductor pollicis brevis (APB) muscle (tested by resisting thumb abduction perpendicular to the palm) and progressive flattening / atrophy of the thenar eminence.

Provocative Physical Examination Maneuvers

Stepwise Management Algorithm

1. First-Line Conservative Therapy: Nocturnal Neutral-Wrist Splinting.
   • Rigid splint holding the wrist in neutral position (0° to 5° of extension), worn every night for at least 6 to 8 weeks.
   • Intracarpal tunnel pressure is lowest at neutral (averaging 5-10 mmHg); flexion or extension elevates pressure beyond 30-50 mmHg, precipitating capillary collapse. Day wear is added if symptoms occur during daytime work activities.
   • Ergonomic workstation modification (keyboard wrist rests, avoiding repetitive power gripping).
2. Second-Line Pharmacotherapy & Injections:
   • Oral NSAIDs provide minimal long-term benefit for nerve compression itself but help coexisting flexor tenosynovitis.
   • Ultrasound-Guided Carpal Tunnel Corticosteroid Injection: 20 to 40 mg of triamcinolone acetonide or methylprednisolone acetate injected deep to the transverse carpal ligament into the flexor tenosynovial sheath. Provides substantial symptomatic relief lasting 1 to 3 months, functioning as an effective therapeutic bridge or non-surgical alternative.
3. Electrodiagnostic Studies (EMG / Nerve Conduction Studies):
   • Not required for initial mild clinical cases. Indicated when the clinical diagnosis is equivocal, if symptoms fail conservative therapy, if motor weakness/atrophy is detected, or for pre-operative confirmation.
   • Findings: Prolonged sensory and motor distal latencies across the wrist, reduced sensory nerve action potential (SNAP) amplitude, and fibrillation potentials on needle EMG (denervation).
4. Surgical Carpal Tunnel Release (Open or Endoscopic):
   • Complete division of the transverse carpal ligament decompresses the carpal tunnel.
   • Absolute Indications: Persistent or progressive symptoms despite 3 to 6 months of conservative therapy; severe sensory loss / two-point discrimination >6 mm; electrodiagnostic evidence of axonal loss; or objective thenar muscle atrophy / APB motor weakness.

---

Cervical and Lumbar Radiculopathy: Neuro-Localization & Red Flags

Radiculopathy is an acute or subacute condition caused by mechanical compression or biochemical inflammation of a spinal nerve root, resulting in pain, paresthesias, sensory loss, motor weakness, and hyporeflexia in the corresponding myotome and dermatome.

Etiology: Herniated Disc vs. Spondylosis

• Younger Patients (<50 years): Herniated nucleus pulposus through a torn annulus fibrosus, causing chemical irritation and physical displacement of the traversing or exiting nerve root.
• Older Patients (>50 years): Degenerative spondylosis, including osteophyte formation, facet joint hypertrophy, ligamentum flavum thickening, and degenerative neuroforaminal stenosis.

Cervical Radiculopathy Localization

Cervical nerve roots exit above their corresponding numbered vertebrae (e.g., the C6 root exits between C5 and C6), except for the C8 root, which exits between C7 and T1.

                 CERVICAL RADICULOPATHY LOCALIZATION

   ROOT   DERMATOME               MOTOR TESTING                REFLEX
   ───────────────────────────────────────────────────────────────────
   C5     Lateral shoulder        Shoulder abduction (Deltoid) Biceps reflex
          (epaulet area)          Elbow flexion (Biceps)
   C6     Lateral forearm,        Elbow flexion (Brachiorad.)  Brachioradialis &
          Thumb & Index finger    Wrist extension (ECRL/ECRB)  Biceps reflex
   C7*    Middle finger           Elbow extension (Triceps)    Triceps reflex
                                  Wrist flexion (FCR)
   C8     Medial forearm,         Finger flexion (FDP/FDS)     No reliable reflex
          Ring & Little finger    Hand intrinsics (Interossei)
   ───────────────────────────────────────────────────────────────────
   *C7 is the MOST COMMON cervical radiculopathy (~60% of all cases).

• Spurling Test (Neck Compression Test): Patient extends the neck, laterally rotates the head toward the symptomatic side, while the examiner applies gentle axial downward force on the vertex. A positive test reproduces sharp, radiating radicular pain down the ipsilateral arm (high specificity >90%, moderate sensitivity ~50%).
• Shoulder Abduction (Bakody) Relief Sign: Patient lifts the symptomatic arm and rests the hand on top of the head. Relief of radicular pain indicates cervical root pathology (reduces tension across the lower cervical roots).

Lumbar Radiculopathy (Sciatica) Localization

In the lumbar spine, nerve roots exit below their numbered vertebrae (e.g., L4 root exits beneath the L4 pedicle). Posterolateral disc herniations typically compress the traversing nerve root (e.g., an L4-L5 herniation compresses the traversing L5 root; an L5-S1 herniation compresses the traversing S1 root).

                  LUMBAR RADICULOPATHY LOCALIZATION

   ROOT   DERMATOME               MOTOR / FUNCTIONAL GAIT      REFLEX
   ───────────────────────────────────────────────────────────────────
   L4     Anteromedial thigh,     Knee extension (Quadriceps)  Patellar reflex
          Knee & Medial malleolus Squat and rise difficulty    (Diminished/absent)
   L5*    Anterolateral leg,      Great toe extension (EHL)    NONE
          Foot dorsum & Big toe   Heel walking difficulty      (No reliable reflex)
   S1*    Posterior calf,         Plantarflexion (Gastroc.)    Achilles reflex
          Sole & Lateral foot     Toe walking difficulty       (Diminished/absent)
   ───────────────────────────────────────────────────────────────────
   *L5 and S1 represent >95% of all lumbar disc herniations.

• Straight Leg Raise (SLR / Lasègue Test): Patient supine; examiner passively elevates the symptomatic leg with the knee fully extended. A positive test reproduces sharp, shooting radicular pain radiating below the knee between 30° and 70° of elevation (Sensitivity ~91%, Specificity ~40%).
• Crossed Straight Leg Raise (Well Leg Raise): Passive elevation of the asymptomatic contralateral leg reproduces radicular pain down the symptomatic leg. Indicates severe nerve root impingement or large central/paracentral disc herniation (Specificity >90%, Sensitivity ~30%).

Conservative Management & Urgent Surgical Indications

• Uncomplicated Radiculopathy: 6 to 8 weeks of active conservative therapy without routine imaging: oral NSAIDs (first-line), short course oral gabapentinoids, early structured physical therapy, and strict avoidance of prolonged bed rest.
• EMERGENCY NEUROSURGICAL RED FLAGS (Mandatory STAT MRI of the Spine):
  1. Cauda Equina Syndrome (L2-S5 Root Compression):
     • Bilateral lower extremity radicular pain and progressive motor weakness;
     • Saddle anesthesia: Loss of sensation over the perineum, perianal region, buttocks, and inner thighs;
     • Urinary retention or overflow incontinence: Elevated post-void residual (PVR >200 mL) due to detrusor arreflexia;
     • Fecal incontinence and loss of anal sphincter resting tone on digital rectal examination.
     • Action: STAT emergency MRI and decompressive laminectomy within 24 to 48 hours to prevent permanent bladder, bowel, and sexual paralysis.
  2. Rapidly Progressive Motor Deficit: E.g., acute foot drop (severe L5 motor loss) or rapidly advancing quadriceps weakness.
  3. Spinal Epidural Abscess or Hematoma: Back pain, fever, focal neurologic deficits, elevated inflammatory markers (ESR/CRP), history of injection drug use, indwelling catheter, or epidural anesthesia.